Advise the patient to read the patient labeling (Medication Guide).
Anemia: Inform patients that WELIREG can cause severe anemia that may require blood transfusions and that red blood cell levels will be monitored routinely during treatment. Advise patients to contact their healthcare provider if the patient experiences any symptoms suggestive of anemia [see Anemia under Precautions].
Hypoxia: Inform patients that WELIREG can cause severe hypoxia that may require discontinuation, supplemental oxygen, or hospitalization; and that oxygen levels will be monitored routinely during treatment. Advise patients to contact their healthcare provider if the patient experiences any symptoms suggestive of hypoxia [see Hypoxia under Precautions].
Embryo-Fetal Toxicity: Advise pregnant women and females of reproductive potential of the risk to a fetus. Advise females to inform their healthcare provider of a known or suspected pregnancy [see Embryo-Fetal Toxicity under Precautions; Pregnancy under Use in Pregnancy & Lactation].
Advise females of reproductive potential to use effective non-hormonal contraception during treatment with WELIREG and for 1 week after the last dose [see Females and Males of Reproductive Potential under Use in Pregnancy & Lactation].
Advise male patients with female partners of reproductive potential to use effective contraception during treatment with WELIREG and for 1 week after the last dose [see Females and Males of Reproductive Potential under Use in Pregnancy & Lactation].
Lactation: Advise females not to breastfeed during treatment with WELIREG and for 1 week after the last dose [see Lactation under Use in Pregnancy & Lactation].
Infertility: Advise male and female patients that WELIREG may impair fertility [see Females and Males of Reproductive Potential under Use in Pregnancy & Lactation].
Dosage and Administration: Instruct patients to take their dose of WELIREG at the same time each day (once daily). Advise patients that WELIREG can be taken with or without food. Each tablet should be swallowed whole [see Recommended Dosage under Dosage & Administration].